Estados financieros detallados de NuCana plc (NCNA): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $1.30, NCNA presenta beneficios negativos (P/E no significativo) y un ROE del -120.66%. La capitalización bursátil es de $8M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | $283000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | $283000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $7.9M | $17.7M | $16.8M | $19.7M | $25.9M | $36.8M | $36.4M | $25.1M | $18.0M | $12.7M |
| Generales y Administrativos | $1.1M | $4.6M | $5.2M | $6.0M | $7.0M | $8.5M | $7.3M | $6.1M | $5.0M | $8.1M |
| Gastos Operativos | $9.0M | $24.0M | $22.0M | $25.7M | $32.9M | $47.9M | $39.1M | $32.8M | $22.8M | $20.1M |
| Beneficio Operativo | -$8.4M | -$22.2M | -$22.0M | -$26.7M | -$36.4M | -$47.9M | -$39.1M | -$32.8M | -$22.8M | -$20.1M |
| EBITDA | -$8.9M | 0 | 0 | 0 | -$28.6M | -$44.4M | -$43.0M | -$30.6M | -$22.5M | -$20.6M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$8.2M | -$25.5M | -$18.1M | -$25.7M | -$36.2M | -$47.8M | -$38.5M | -$32.0M | -$22.5M | -$30.5M |
| Impuestos | -$2.1M | -$2.4M | -$4.2M | -$4.2M | -$5.5M | -$7.3M | -$6.4M | -$4.4M | -$3.5M | -$1.2M |
| Beneficio Neto | -$6.0M | -$23.1M | -$13.8M | -$21.4M | -$30.7M | -$40.5M | -$32.0M | -$27.6M | -$19.0M | -$29.4M |
| BPA | $1359.22 | $-4747.43 | $-2886.02 | $-4224.99 | $-5193.15 | $-5355.91 | $-3775.53 | $-3266.68 | $-1635.98 | $-17.20 |
| BPA Diluido | $1359.22 | $-4747.43 | $-2886.02 | $-4224.99 | $-5193.15 | $-5355.91 | $-3775.53 | $-3266.68 | $-1635.98 | $-17.20 |
| Acciones en Circulación (Diluidas) | $6362 | $6262 | $6394 | $6465 | $7576 | $10408 | $10447 | $10514 | $14838 | $2.2M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $20.0M | $86.7M | $77.0M | $52.0M | $87.4M | $60.3M | $41.9M | $17.2M | $6.7M | $24.3M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $2.6M | $4.8M | $4.8M | $9.1M | $10.6M | $8.2M | $7.0M | $5.8M | $4.6M | $1.9M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $25.8M | $94.0M | $83.6M | $65.2M | $101.8M | $71.6M | $54.9M | $25.0M | $12.3M | $26.9M |
| Inmovilizado Material | $18000 | $358000 | $427000 | $1.1M | $1.2M | $851000 | $866000 | $521000 | $197000 | $658000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $1.4M | $1.9M | $3.1M | $4.0M | $4.8M | $2.4M | $2.4M | $2.1M | $2.2M | $2.2M |
| Activos Totales | $27.2M | $96.4M | $87.2M | $70.3M | $107.8M | $77.5M | $58.3M | $27.8M | $14.8M | $29.8M |
| Cuentas por Pagar | $728000 | $1.1M | $2.5M | $2.4M | $2.3M | $1.8M | $4.8M | $3.4M | $2.7M | $522000 |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $2.0M | $2.9M | $5.6M | $6.2M | $8.1M | $11.7M | $19.3M | $12.7M | $8.7M | $4.8M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $2.0M | $2.9M | $5.6M | $6.7M | $8.6M | $11.9M | $19.8M | $12.9M | $8.8M | $5.5M |
| Reservas | -$22.3M | -$45.2M | -$58.8M | -$80.1M | -$110.6M | -$149.7M | -$180.6M | -$207.7M | -$224.3M | -$252.3M |
| Patrimonio Neto | $25.2M | $93.4M | $81.6M | $63.5M | $99.2M | $65.5M | $38.5M | $14.9M | $6.0M | $24.3M |
| Deuda Total | 0 | 0 | 0 | $806000 | $645000 | $371000 | $639000 | $396000 | $190000 | $676000 |
| Deuda Neta | -$20.0M | -$86.7M | -$77.0M | -$51.2M | -$86.7M | -$59.9M | -$41.3M | -$16.8M | -$6.6M | -$23.6M |
| Capital Circulante | $23.8M | $91.1M | $78.0M | $59.0M | $93.7M | $59.9M | $35.6M | $12.3M | $3.6M | $22.1M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$6.0M | -$23.1M | -$13.8M | -$21.4M | -$30.7M | -$40.5M | -$32.0M | -$27.6M | -$19.0M | -$29.4M |
| Amortizaciones | $101000 | $194000 | $371000 | $718000 | $890000 | $942000 | $732000 | $575000 | $522000 | $274000 |
| Compensación en Acciones | $1.1M | $11.7M | $1.8M | $3.2M | $4.3M | $6.7M | $4.9M | $3.9M | $1.6M | $10.0M |
| Cambio en Capital Circulante | -$3.2M | $1.4M | $3.5M | -$2.1M | $1.9M | $4.1M | $3.7M | -$1.3M | -$2.2M | -$3.7M |
| Flujo de Caja Operativo | -$9.3M | -$8.7M | -$12.2M | -$23.8M | -$21.6M | -$23.8M | -$23.2M | -$26.4M | -$19.1M | -$7.5M |
| Inversiones (CapEx) | -$554000 | -$1.1M | -$1.6M | -$1.3M | -$1.6M | -$1.1M | -$518000 | -$478000 | -$293000 | -$193000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$9.8M | -$9.8M | -$13.8M | -$25.1M | -$23.3M | -$24.9M | -$23.7M | -$26.9M | -$19.4M | -$7.7M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | -100.0% | |||||||||
| Crecimiento Beneficio Neto (anual) | -281.6% | +40.0% | -54.7% | -43.3% | -32.1% | +21.0% | +13.7% | +31.2% | -54.5% | |
| Crecimiento BPA (anual) | -449.3% | +39.2% | -46.4% | -22.9% | -3.1% | +29.5% | +13.5% | +49.9% | +98.9% | |
| Cambio en Acciones (anual) | -1.6% | +2.1% | +1.1% | +17.2% | +37.4% | +0.4% | +0.6% | +41.1% | +15038.9% | |
| Crecimiento FCF (anual) | +0.2% | -41.3% | -81.2% | +7.3% | -7.0% | +4.9% | -13.7% | +27.9% | +60.5% | |
| Margen Bruto | 100.0% | |||||||||
| Margen Operativo | -7860.8% | |||||||||
| Margen EBITDA | 0.0% | |||||||||
| Margen Neto | -8157.2% | |||||||||
| Margen FCF | -3464.0% | |||||||||
| Tasa Impositiva Efectiva | 25.9% | 9.4% | 23.4% | 16.5% | 15.2% | 15.2% | 16.7% | 13.7% | 15.4% | 3.8% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-1543.23 | $-1565.47 | $-2165.78 | $-3881.52 | $-3069.03 | $-2391.33 | $-2266.30 | $-2560.11 | $-1308.20 | $-3.41 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $6362 | $6262 | $6394 | $6465 | $7576 | $10408 | $10447 | $10514 | $14838 | $2.2M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -120.66% |
| Rentabilidad sobre capital invertido | -77.17% |
| Rentabilidad sobre activos | -98.39% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.03 |
| Ratio corriente | 5.60 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -12.10 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | 48.12 | -7.88 | -19.69 | -5.44 | -3.16 | -1.64 | -0.72 | -0.36 | -0.12 | -0.16 |
| P/VC | 16.49 | 2.51 | 4.45 | 2.34 | 1.25 | 1.40 | 0.74 | 0.82 | 0.47 | 0.25 |
| P/V | 0.00 | 827.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | -7860.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | -8157.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: CASI · CLGN · CLSD · ENLV · GDTC · LSTA · MTVA
Explorar sector: Healthcare · Biotechnology
Más secciones de NCNA: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones